Accept Cookies?
Provided by OpenGlobal E-commerce

Please wait while your page loads ...

FARAFARA Cure FA

STEADFAST Background for the Friedreich's Ataxia community

The Friedreich’s Ataxia Research Alliance (FARA) and Horizon Pharma plc would like to share additional background regarding the Phase 3 STEADFAST clinical trial, as well as information about our ongoing collaboration moving forward. We have received many questions among those who participated in the clinical trials, as well as others in the FA community. We want to ensure that you know we have heard your feedback, and that we are working together in the following ways.

Read more HERE


About the Author

Jen Farmer

Jen Farmer

Executive Director

SHARE

FacebookTwitterLinkedinShare on Google+
Event H.jpg

 

Archived in
  Scientific News


 

 

Tagged in
FARA Scientific News